扶桑薬品工業(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証PRM | 医薬品 | 4538/E00953 | Fuso Pharmaceutical Industries, Ltd. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2018/06/15 | 日証協 | 31,700株 | +1.93% | 900株 | +350% | 22,313株 | -0.89% | 300株 | -70% |
2018/06/08 | 日証協 | 31,100株 | +0.65% | 200株 | -98.95% | 22,513株 | -0.88% | 1,000株 | -92.65% |
2018/06/01 | 日証協 | 30,900株 | +69.78% | 19,000株 | +533.33% | 22,713株 | +39.23% | 13,600株 | +1600% |
2018/05/25 | 日証協 | 18,200株 | +10.98% | 3,000株 | +57.89% | 16,313株 | 0% | 800株 | +700% |
2018/05/18 | 日証協 | 16,400株 | -6.67% | 1,900株 | -75.09% | 16,313株 | -26.89% | 100株 | -83.33% |
2018/05/11 | 日証協 | 17,572株 | +32.12% | 7,628株 | +1425.6% | 22,313株 | -3.04% | 600株 | +50% |
2018/05/02 | 日証協 | 13,300株 | +0.76% | 500株 | -73.68% | 23,013株 | -0.43% | 400株 | -84% |
2018/04/27 | 日証協 | 13,200株 | -8.33% | 1,900株 | -85.82% | 23,113株 | +18.45% | 2,500株 | +92.31% |
2018/04/20 | 日証協 | 14,400株 | -2.7% | 13,400株 | -49.24% | 19,513株 | -1.51% | 1,300株 | -62.86% |
2018/04/13 | 日証協 | 14,800株 | -18.23% | 26,400株 | -21.66% | 19,813株 | -30.76% | 3,500株 | -80.11% |
2018/04/06 | 日証協 | 18,100株 | +75.73% | 33,700株 | +78.31% | 28,613株 | +33.22% | 17,601株 | +60.01% |
2018/03/30 | 日証協 | 10,300株 | -66.01% | 18,900株 | -2.58% | 21,478株 | -13.44% | 11,000株 | -32.1% |
2018/03/23 | 日証協 | 30,300株 | +36.49% | 19,400株 | -26.24% | 24,813株 | -4.98% | 16,200株 | +118.92% |
2018/03/16 | 日証協 | 22,200株 | -7.88% | 26,300株 | +15.86% | 26,114株 | -16.87% | 7,400株 | +17.46% |
2018/03/09 | 日証協 | 24,100株 | -17.47% | 22,700株 | -41.79% | 31,414株 | +7.53% | 6,300株 | -38.24% |
2018/03/02 | 日証協 | 29,200株 | +16.8% | 39,000株 | +128.07% | 29,214株 | +24.22% | 10,200株 | +138.76% |
2018/02/23 | 日証協 | 25,000株 | -35.62% | 17,100株 | +37.9% | 23,518株 | -9.01% | 4,272株 | -0.67% |
2018/02/16 | 日証協 | 38,832株 | +19% | 12,400株 | -49.8% | 25,846株 | +8.39% | 4,301株 | -41.08% |
2018/02/09 | 日証協 | 32,632株 | +9.39% | 24,700株 | -23.29% | 23,846株 | +10.16% | 7,300株 | +329.41% |
※株式分割は考慮していませんのでご注意ください。